Our Grants - Helmsley Charitable Trust

GRANT	DATE	AMOUNT	PROGRAM
Kaiser Foundation Health Plan of Georgia, Inc. Expansion of the T1DES Pilot to a Public Hospital	04.26.2023	$546,967.00	Type 1 Diabetes, Improve Outcomes
The Imperial College of Science, Technology and Medicine Immunological mechanisms underlying the genetic basis for natural T1D protection	04.12.2023	$1,112,592.00	Type 1 Diabetes, Prevent & Delay
American Diabetes Association, Inc. Training and Mentorship Programs	03.14.2023	$2,416,146.00	Type 1 Diabetes, Improve Outcomes
DreaMed Diabetes Ltd. Increasing access to decision support tools for improved insulin dosing for people with diabetes	02.23.2023	$2,850,000.00	Type 1 Diabetes, Improve Outcomes
University Hospitals Health System, Inc. Type 1 Diabetes Financial Toolkit for Emerging Adults	02.22.2023	$2,251,238.00	Type 1 Diabetes, Improve Outcomes
Beyond Type 1 Capacity Building Support	02.22.2023	$4,400,000.00	Type 1 Diabetes, Improve Outcomes
World Health Organization Strengthening the Capacity of the Global Diabetes Compact	01.11.2023	$10,680,670.00	Type 1 Diabetes, Improve Outcomes
JDRF Australia ENDIA Follow up 2023-2025 + Samples Analysis RFA	11.08.2022	$4,790,735.00	Type 1 Diabetes, Prevent & Delay
The Trustees of Columbia University in the City of New York Support for T1D Transition Programs	11.08.2022	$600,000.00	Type 1 Diabetes, Improve Outcomes
Center for Health Care Strategies Inc CGM Medicaid Access Accelerator - Targeted Resources and Technical Assistance to Improve Care for People Living with Diabetes Who Use Insulin	11.08.2022	$2,282,795.00	Type 1 Diabetes, Improve Outcomes
HealthPartners Institute Piloting the Process of Electronically Collecting Patient Generated Continuous Glucose Monitoring Data to Accelerate the Development of New Diabetes-Related Measure Concepts	11.08.2022	$751,067.00	Type 1 Diabetes, Improve Outcomes
American College of Diabetology Inc Improve the diabetes training opportunities for PCPs	11.08.2022	$2,991,988.00	Type 1 Diabetes, Improve Outcomes
Medical University of South Carolina Engineered dendritic cell based robust antigen specific therapy for type 1 diabetes	11.08.2022	$825,000.00	Type 1 Diabetes, Prevent & Delay
University of Florida Human Atlas of Neonatal Development and Early Life-Immunity (HANDEL-I) continuation	11.08.2022	$2,072,489.00	Type 1 Diabetes, Prevent & Delay
University of North Carolina at Chapel Hill Development of a Continuous Insulin Sensor	11.08.2022	$3,163,533.00	Type 1 Diabetes, Improve Outcomes
Mayo Clinic Development and Evaluation of a Novel Algorithm for AID control for Pregnant Women with T1D	11.08.2022	$1,081,500.00	Type 1 Diabetes, Improve Outcomes
Oregon Health & Science University An MDI Decision Support System with CDCES and Behavioral Health Support	10.25.2022	$4,364,007.00	Type 1 Diabetes, Improve Outcomes
King's College London Prenatal drivers of infant ISlet Autoimmunity (PISA study)	10.25.2022	$2,422,655.00	Type 1 Diabetes, Prevent & Delay
King's College London Characterising ‘NoGo Autoimmunity' in genetically protected (HLA-DQ6+) subjects	10.25.2022	$757,700.00	Type 1 Diabetes, Prevent & Delay
Region Hovedstaden Can microchimerism explain differences in parental type 1 diabetes conferred risk of offspring type 1 diabetes?	10.25.2022	$592,935.00	Type 1 Diabetes, Prevent & Delay
You can filter rows: 1 - 20 of 820 < > Last